Frankfurt
19.03.26 | 15:25
0,129 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| LEES PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| Di | LEE'S PHARM (00950): NOTICE OF BOARD MEETING | 5 | HKEx | ||
| 27.01. | LEE'S PHARM (00950): VOLUNTARY ANNOUNCEMENT - FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR ADASUVE | - | HKEx | ||
| 22.12.25 | LEE'S PHARM (00950): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS | 5 | HKEx | ||
| 18.12.25 | LEE'S PHARM (00950): PASSING AWAY OF MICHELE DALLA LIBERA | 1 | HKEx | ||
| 11.12.25 | Lee's Pharmaceutical Holdings Limited: Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights | 552 | PR Newswire | Acquisition of Staccato One Breath Technology, a proprietary platform technology with broad therapeutic potentialSynergistic and complementary to Lee's Pharm's existing products pipeline... ► Artikel lesen | |
| 11.12.25 | Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights | 356 | PR Newswire | Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential
Synergistic and complementary to Lee's Pharm's existing products... ► Artikel lesen | |
| 08.12.25 | LEE'S PHARM (00950): DISCLOSEABLE TRANSACTION - ACQUISITION OF ASSETS | 1 | HKEx | ||
| 15.10.25 | LEE'S PHARM (00950): GRANT OF SHARE OPTIONS | 2 | HKEx | ||
| 12.09.25 | Dividendenbekanntmachungen (12.09.2025) | 12.771 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSA GROUP LIMITED ADR US00400T1025 0,887 USD 0,7558 EUR ACADIAN ASSET MANAGEMENT INC US10948W1036 0,01 USD 0,0085 EUR ALBEMARLE... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 118,32 | -0,12 % | Laufende Fusionskontrollverfahren: Gilead Sciences, Foster City, CA/USA; Erwerb sämtlicher Anteile an und Kontrolle über die Arcellx, Redwood City, CA/USA | Datum der Anmeldung:13.03.2026Aktenzeichen:B3-41/26Unternehmen:Gilead Sciences, Foster City, CA/USA; Erwerb sämtlicher Anteile an und Kontrolle über die Arcellx, Redwood City, CA/USAProduktmärkte:Hämatologie... ► Artikel lesen | |
| ZOETIS | 99,48 | -0,56 % | Zoetis auf dem KeyBanc Forum: Strategisches Wachstum trotz Herausforderungen | ||
| SINOPHARM | 2,267 | -0,57 % | Reed Sinopharm Exhibitions (RSE): PCHi 2026: World's Largest Cosmetics Ingredients Exhibition Opens in Hangzhou | 860+ exhibitors from 26 countries and regions across 70,000 sqmClose to 50 new product launches, including global and China debuts295 product submissions and 19 engineer nominations for the... ► Artikel lesen | |
| CSPC PHARMA | 0,980 | +2,00 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - GLP-1/GIP RECEPTOR DUAL-BIASED AGONIST POLYPEPTIDE LONG-ACTING INJECTION (SYH2082 INJECTION) OBTAINS CLINICAL ... | ||
| WUXI BIOLOGICS | 3,659 | -0,64 % | WuXi Biologics Jumps On Pact With Vertex Pharma For T-Cell Engager In Autoimmune Disease | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - WuXi Biologics (2269. HK,WXIBF), a Contract Research, Development, and Manufacturing Organisation, announced on Tuesday that it has signed a license and... ► Artikel lesen | |
| SHANGHAI FOSUN PHARMACEUTICAL | 2,002 | +1,26 % | FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY | ||
| GEDEON RICHTER | 29,540 | -1,66 % | Gedeon Richter Plc.: Extraordinary Information | ||
| DR REDDYS | 12,000 | +0,84 % | Dr Reddy's launches Obeda (semaglutide) in India for Type 2 Diabetes | ||
| MEDIPHARM LABS | 0,040 | -5,16 % | MediPharm Labs Corp.: MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO | TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids... ► Artikel lesen | |
| ASPEN PHARMACARE | 6,700 | +1,52 % | ASPEN PHARMACARE HOLDINGS LIMITED - Distribution of circular to shareholders and notice of general meeting | ||
| SHANGHAI PHARMACEUTICALS | 1,270 | +4,96 % | SH PHARMA (02607): NOTICE OF BOARD MEETING | ||
| LUYE PHARMA | 0,256 | -3,76 % | LUYE PHARMA (02186): NOTICE OF BOARD MEETING | ||
| SIHUAN PHARMACEUTICAL HOLDINGS GROUP | 0,148 | -1,99 % | SIHUAN PHARM (00460): NOTICE OF BOARD MEETING | ||
| CHINA RESOURCES PHARMACEUTICAL | 0,478 | 0,00 % | CHINARES PHARMA (03320): ANNOUNCEMENT PRINCIPAL FINANCIAL INFORMATION OF CR SANJIU FOR THE YEAR ENDED 31 DECEMBER 2025 | ||
| HANSOH PHARMACEUTICAL | 3,500 | -1,13 % | HANSOH PHARMA (03692): DATE OF BOARD MEETING |
LEES PHARMACEUTICAL HOLDINGS LTD gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,129 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LEES PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.